Literature DB >> 3402020

Reversal of prolonged postoperative muscle rigidity by dantrolene: a case report.

S K Dhandha1.   

Abstract

The use of dantrolene to reverse severe unexplained postanaesthetic muscle rigidity in a previously "healthy" 13-year-old male is described. Anaesthesia was induced with thiopentone. After intubation with pancuronium, the patient had an entirely uneventful nitrous oxide, oxygen and halothane anaesthetic. Immediately following reversal of the relaxant, the patient developed generalized muscle tightness and rigidity involving the trunk and extremities. This was prolonged and severe enough to interfere with adequate ventilation. The patient also had a prolonged recovery from the anaesthetic. After ruling out malignant hyperthermia and some other causes of rigidity, a tentative diagnosis of myotonia was made. The symptoms responded to IV dantrolene in a total dose of 2.0 mg.kg-1. Further testing failed to establish a definite diagnosis. Dantrolene could be a useful drug in treating such unexplained muscle rigidity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402020     DOI: 10.1007/BF03010868

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

1.  Acute respiratory arrest and rigidity after anesthesia with sufentanil: a case report.

Authors:  J Chang; K J Fish
Journal:  Anesthesiology       Date:  1985-12       Impact factor: 7.892

2.  Relief of myotonia by dantrolene in experimental myotonia.

Authors:  A Eberstein; J Goodgold
Journal:  Exp Neurol       Date:  1978-12       Impact factor: 5.330

Review 3.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

4.  Anaesthetic problems in myotonic dystrophy. A case report and review of the Aberdeen experience comprising 48 general anaesthetics in a further 16 patients.

Authors:  L M Aldridge
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

5.  Postoperative rigidity following fentanyl anesthesia.

Authors:  C M Christian; J L Waller; C C Moldenhauer
Journal:  Anesthesiology       Date:  1983-03       Impact factor: 7.892

6.  Neuroleptic malignant syndrome: response to dantrolene sodium.

Authors:  D C May; S W Morris; R M Stewart; B J Fenton; F A Gaffney
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

7.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

8.  Myotonia and neuromuscular blocking agents.

Authors:  M M Mitchell; H H Ali; J J Savarese
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

9.  Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.

Authors:  M Goulon; P de Rohan-Chabot; D Elkharrat; P Gajdos; C Bismuth; F Conso
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

Review 10.  Malignant hyperthermia.

Authors:  G A Gronert
Journal:  Anesthesiology       Date:  1980-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.